Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2005 2
2006 5
2007 3
2008 2
2009 2
2010 5
2011 2
2012 5
2013 5
2014 5
2015 6
2016 7
2017 6
2018 9
2019 13
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.
Nallasamy P, Chava S, Verma SS, Mishra S, Gorantla S, Coulter DW, Byrareddy SN, Batra SK, Gupta SC, Challagundla KB. Nallasamy P, et al. Among authors: Gorantla S. Semin Cancer Biol. 2018 Oct;52(Pt 2):53-65. doi: 10.1016/j.semcancer.2017.11.009. Epub 2017 Nov 28. Semin Cancer Biol. 2018. PMID: 29196189 Free PMC article. Review.
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N. Vengoji R, et al. Among authors: Gorantla S. J Exp Clin Cancer Res. 2019 Jun 18;38(1):266. doi: 10.1186/s13046-019-1264-2. J Exp Clin Cancer Res. 2019. PMID: 31215502 Free PMC article.
Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice.
Mathews S, Branch Woods A, Katano I, Makarov E, Thomas MB, Gendelman HE, Poluektova LY, Ito M, Gorantla S. Mathews S, et al. Among authors: Gorantla S. Mol Neurodegener. 2019 Mar 5;14(1):12. doi: 10.1186/s13024-019-0311-y. Mol Neurodegener. 2019. PMID: 30832693 Free PMC article.
Neuropharmacologic Approaches to Restore the Brain's Microenvironment.
Li W, Tong HI, Gorantla S, Poluektova LY, Gendelman HE, Lu Y. Li W, et al. Among authors: Gorantla S. J Neuroimmune Pharmacol. 2016 Sep;11(3):484-94. doi: 10.1007/s11481-016-9686-5. Epub 2016 Jun 28. J Neuroimmune Pharmacol. 2016. PMID: 27352074 Free PMC article. Review.
Neurotheranostics as personalized medicines.
Kevadiya BD, Ottemann BM, Thomas MB, Mukadam I, Nigam S, McMillan J, Gorantla S, Bronich TK, Edagwa B, Gendelman HE. Kevadiya BD, et al. Among authors: Gorantla S. Adv Drug Deliv Rev. 2019 Aug;148:252-289. doi: 10.1016/j.addr.2018.10.011. Epub 2018 Oct 26. Adv Drug Deliv Rev. 2019. PMID: 30421721 Free article. Review.
Metabolic drift in the aging brain.
Ivanisevic J, Stauch KL, Petrascheck M, Benton HP, Epstein AA, Fang M, Gorantla S, Tran M, Hoang L, Kurczy ME, Boska MD, Gendelman HE, Fox HS, Siuzdak G. Ivanisevic J, et al. Among authors: Gorantla S. Aging (Albany NY). 2016 May;8(5):1000-20. doi: 10.18632/aging.100961. Aging (Albany NY). 2016. PMID: 27182841 Free PMC article.
Creation of a long-acting nanoformulated dolutegravir.
Sillman B, Bade AN, Dash PK, Bhargavan B, Kocher T, Mathews S, Su H, Kanmogne GD, Poluektova LY, Gorantla S, McMillan J, Gautam N, Alnouti Y, Edagwa B, Gendelman HE. Sillman B, et al. Among authors: Gorantla S. Nat Commun. 2018 Feb 6;9(1):443. doi: 10.1038/s41467-018-02885-x. Nat Commun. 2018. PMID: 29402886 Free PMC article.
Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice.
McMillan JM, Cobb DA, Lin Z, Banoub MG, Dagur RS, Branch Woods AA, Wang W, Makarov E, Kocher T, Joshi PS, Quadros RM, Harms DW, Cohen SM, Gendelman HE, Gurumurthy CB, Gorantla S, Poluektova LY. McMillan JM, et al. Among authors: Gorantla S. J Pharmacol Exp Ther. 2018 May;365(2):272-280. doi: 10.1124/jpet.117.247288. Epub 2018 Feb 23. J Pharmacol Exp Ther. 2018. PMID: 29476044 Free PMC article.
Broad Spectrum Mixed Lineage Kinase Type 3 Inhibition and HIV-1 Persistence in Macrophages.
Saminathan P, Kevadiya BD, Marker DF, Gendelman HE, Gorantla S, Gelbard HA. Saminathan P, et al. Among authors: Gorantla S. J Neuroimmune Pharmacol. 2019 Mar;14(1):44-51. doi: 10.1007/s11481-018-09829-8. Epub 2019 Jan 7. J Neuroimmune Pharmacol. 2019. PMID: 30617749 Free PMC article. Review.
Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs.
Gnanadhas DP, Dash PK, Sillman B, Bade AN, Lin Z, Palandri DL, Gautam N, Alnouti Y, Gelbard HA, McMillan J, Mosley RL, Edagwa B, Gendelman HE, Gorantla S. Gnanadhas DP, et al. Among authors: Gorantla S. J Clin Invest. 2017 Mar 1;127(3):857-873. doi: 10.1172/JCI90025. Epub 2017 Jan 30. J Clin Invest. 2017. PMID: 28134625 Free PMC article.
73 results
Jump to page
Feedback